Cas no 37153-52-9 (Bromoclenbuterol)

Bromoclenbuterol is a β?-adrenergic agonist with bronchodilatory and tocolytic properties, primarily used in veterinary medicine to treat respiratory conditions in livestock. Its mechanism of action involves selective stimulation of β?-adrenergic receptors, leading to smooth muscle relaxation in the airways and improved airflow. The compound exhibits high potency and prolonged duration of action, making it effective for managing bronchospasms and chronic obstructive pulmonary disease (COPD) in animals. Bromoclenbuterol is also noted for its lipolytic effects, though its use is strictly regulated due to potential residues in food-producing animals. Proper dosing and adherence to withdrawal periods are critical to ensure compliance with food safety standards.

Bromoclenbuterol structure

Product Name:Bromoclenbuterol

CAS No:37153-52-9

MF:C₁₂H₁₈BrClN₂O

MW:321.641121387482

CID:314525

PubChem ID:2763157

Update Time:2025-06-15

Bromoclenbuterol Chemical and Physical Properties

Names and Identifiers

- Benzenemethanol,4-amino-3-bromo-5-chloro-a-[[(1,1-dimethylethyl)amino]methyl]-
- 1-(4-amino-3-bromo-5-chlorophenyl)-2-(tert-butylamino)ethanol
- BROMOCLENBUTEROL
- Clenbuterol Impurity F
- Benzenemethanol, 4-amino-3-bromo-5-chloro-alpha-[[(1,1-dimethylethyl)amino]methyl]-
- CLENBUTEROL HYDROCHLORIDE IMPURITY F [EP IMPURITY]
- (1RS)-1-(4-amino-3-bromo-5-chlorophenyl)-2-[(1,1-dimethylethyl)amino]ethanol
- NS00040820
- 4-Amino-3-bromo-5-chloro-alpha-[[(1,1-dimethylethyl)amino]methyl]benzenemethanol
- SCHEMBL10614327
- DTXSID80376770
- 4KJ88YP4R5
- Bromchlorbuterol
- FT-0730841
- 37153-52-9
- Bromoclenbuterol
- Inchi： 1S/C12H18BrClN2O/c1-12(2,3)16-6-10(17)7-4-8(13)11(15)9(14)5-7/h4-5,10,16-17H,6,15H2,1-3H3
- InChI Key： RBROAKIHDILEQG-UHFFFAOYSA-N
- SMILES： BrC1=C(C(=CC(=C1)C(CNC(C)(C)C)O)Cl)N

Computed Properties

Exact Mass: 320.02900
Monoisotopic Mass: 320.029
Isotope Atom Count: 0
Hydrogen Bond Donor Count: 3
Hydrogen Bond Acceptor Count: 3
Heavy Atom Count: 17
Rotatable Bond Count: 4
Complexity: 247
Covalently-Bonded Unit Count: 1
Defined Atom Stereocenter Count: 0
Undefined Atom Stereocenter Count : 1
Defined Bond Stereocenter Count: 0
Undefined Bond Stereocenter Count: 0
Topological Polar Surface Area: 58.3A^2
XLogP3: 2.3

Experimental Properties

Density: 1.424
Boiling Point: 430.3°Cat760mmHg
Flash Point: 214°C
Refractive Index: 1.59
PSA: 58.28000
LogP: 4.07830

Bromoclenbuterol Security Information

Signal Word：warning
Hazard Statement： H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
Warning Statement： P264+P280+P305+P351+P338+P337+P313
Safety Instruction： H303+H313+H333
Storage Condition：Store at recommended temperature

Bromoclenbuterol Customs Data

HS CODE：2922199090
Customs Data：

China Customs Code:
2922199090

Overview:

2922199090. Other amino alcohols and their ethers,Esters and their salts(Except those containing more than one oxygen-containing group). VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:30.0%

Declaration elements:

Product Name, component content, use to, The color of ethanolamine and its salt should be reported, The package of ethanolamine and its salt shall be declared

Summary:

2922199090. other amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

Bromoclenbuterol Pricemore >>

Related Categories	No.	Product Name	Cas No.	Specification	Price	update time
TRC	B606535-2.5mg	Bromoclenbuterol	37153-52-9	2.5mg	$ 190.00	2023-04-18
TRC	B606535-10mg	Bromoclenbuterol	37153-52-9	10mg	$ 718.00	2023-04-18
TRC	B606535-25mg	Bromoclenbuterol	37153-52-9	25mg	$ 1499.00	2023-04-18
TRC	B606535-100mg	Bromoclenbuterol	37153-52-9	100mg	$ 4500.00	2023-09-08

Bromoclenbuterol Suppliers

Tiancheng Chemical (Jiangsu) Co., Ltd

Gold Member

Audited Supplier

(CAS:37153-52-9)Bromchlorbuterol

Order Number:LE10655

Stock Status:in Stock

Quantity:25KG,200KG,1000KG

Purity:99%

Pricing Information Last Updated:Friday, 20 June 2025 12:03

Price ($):discuss personally

Email:[email protected]

Bromoclenbuterol Related Literature

1. Enantiomorphic symmetry breaking in crystallization of molten sodium chlorate?

Martin R. Ward,Gary W. Copeland,Andrew J. Alexander Chem. Commun., 2010,46, 7634-7636
2. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??

Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
3. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?

Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
4. Enantiopure 2,6-disubstituted piperidines bearing one alkene- or alkyne-containing substituent: preparation and application to total syntheses of indolizidine-alkaloids?

Hui Liu,Deyong Su,Guolin Cheng,Jimin Xu,Xinyan Wang,Yuefei Hu Org. Biomol. Chem., 2010,8, 1899-1904
5. Enantiomerically pure 1,3,2-dioxaborolanes: new reagents for the hydroboration of alkynes

Chem. Commun., 1998, 2651-2652

Related Categories

Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aniline and substituted anilines 2-bromoanilines

Additional information on Bromoclenbuterol

Bromoclenbuterol (CAS No. 37153-52-9): A Comprehensive Overview of Its Chemical Profile and Emerging Applications

Bromoclenbuterol, identified by the Chemical Abstracts Service Number (CAS No.) 37153-52-9, is a compound that has garnered significant attention in the field of pharmaceutical research and biochemical studies. As a derivative of the well-known β?-adrenergic receptor agonist clenbuterol, Bromoclenbuterol exhibits distinct pharmacological properties that make it a subject of interest for both therapeutic and experimental purposes. This article provides an in-depth exploration of the chemical characteristics, pharmacological effects, and the latest research findings associated with Bromoclenbuterol.

The molecular structure of Bromoclenbuterol (CAS No. 37153-52-9) incorporates a bromine substituent at the clencainyl group, which is believed to modulate its receptor binding affinity and metabolic stability. This structural modification has been investigated for its potential to enhance selectivity and reduce side effects compared to its parent compound. The compound’s chemical formula is C₁₂H₁₈BrNO₃, reflecting its molecular weight and composition.

In recent years, Bromoclenbuterol has been studied for its potential applications in treating respiratory disorders. Unlike clenbuterol, which is primarily used as a bronchodilator in veterinary medicine, Bromoclenbuterol has shown promise in preclinical trials for its ability to stimulate β?-adrenergic receptors with higher specificity. This property could lead to fewer cardiovascular side effects, making it a more suitable candidate for human therapeutic use. Research published in peer-reviewed journals indicates that Bromoclenbuterol may offer improved efficacy in conditions such as asthma and chronic obstructive pulmonary disease (COPD).

The pharmacokinetic profile of Bromoclenbuterol (CAS No. 37153-52-9) has also been a focus of scientific investigation. Studies have demonstrated that the compound exhibits a relatively short half-life, which could influence its dosing regimen and potential for accumulation in biological systems. Additionally, the presence of the bromine atom appears to enhance its lipophilicity, potentially allowing for better penetration across cellular membranes. These characteristics are critical for determining its bioavailability and therapeutic window.

Emerging research suggests that Bromoclenbuterol may have applications beyond respiratory medicine. Preliminary findings indicate that it could possess anabolic properties, making it attractive for studying muscle growth and wasting conditions. The compound’s ability to activate β?-adrenergic receptors might also contribute to its potential use in metabolic disorders, such as obesity and type 2 diabetes. However, further clinical trials are necessary to validate these hypotheses and establish safe dosages.

The synthesis of Bromoclenbuterol (CAS No. 37153-52-9) involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. The bromination step is particularly critical, as it determines the position and reactivity of the bromine substituent on the molecular framework. Advances in synthetic methodologies have enabled more efficient production processes, which could facilitate broader research applications.

Ethical considerations are paramount when investigating compounds like Bromoclenbuterol. While preclinical studies have provided promising insights into its potential benefits, human trials must be conducted under stringent regulatory frameworks to ensure patient safety and data integrity. Collaborative efforts between academic institutions and pharmaceutical companies are essential for translating laboratory findings into viable therapeutic options.

The future of Bromoclenbuterol research lies in exploring its mechanisms of action and identifying novel therapeutic targets. By leveraging cutting-edge techniques such as computational modeling and high-throughput screening, scientists can uncover new applications for this compound. Additionally, investigating its interactions with other biological pathways may reveal synergistic effects that could enhance its clinical utility.

In conclusion, Bromoclenbuterol, with its CAS Number 37153-52-9, represents a fascinating compound with diverse potential applications in medicine and biotechnology. Its unique chemical properties and pharmacological effects make it a valuable subject for ongoing research. As scientific understanding continues to evolve, the possibilities for utilizing this compound in addressing various health challenges appear promising.

37153-52-9 (Bromoclenbuterol) Related Products

Recommended suppliers